Scoutby Fusion42
Open Waypoint Bio in the live Scout dashboard →

Explore: Biotech · Drug Discovery · Series A · United States · China

Waypoint Bio

Series A · 🇺🇸 New York City, United States · Founded 2021 · 11-50 employees

Website

AI-driven cell therapy startup developing in vivo CAR T therapeutics using spatial pooled screening and computer vision. Waypoint Bio is a healthtech, deeptech and cell therapy startup based in New York City, United States, founded 2021, at Series A stage, with $20M raised to date.

Waypoint Bio is tracked live on Scout, Fusion42's database of newly funded startups — its profile updates as new rounds, backers and Wire analysis land.

Total raised

$20M

Stage

Series A

Business model

SaaS

Key differentiator

Its proprietary in vivo spatial pooled screening platform generates spatial, single-cell functional data from thousands of CAR T designs in parallel, enabling faster optimization than traditional serial testing.

Target customer

biopharma and drug development organizations developing advanced cell therapies, especially oncology-focused R&D teams

Sectors

healthtechdeeptechcell therapybiotechAIdrug discoveryoncology

Funding rounds

Series A

1 June 2026

$20M

Led by Amplify Partners

With General Catalyst, Time BioVentures, Mitsui Global Investments, Lux Capital and Hummingbird Ventures

Round details →Source ↗

Key investors

Hummingbird Ventures, Recode Ventures, Fifty Years, Builders VC, Dimension Capital, FPV Fund, Kinnevik, True Ventures

Notable achievements

Backed by

Team enrichment — names, roles, LinkedIn, X and email where availableSign in to view

Frequently asked questions

What does Waypoint Bio do?
AI-driven cell therapy startup developing in vivo CAR T therapeutics using spatial pooled screening and computer vision.
Where is Waypoint Bio based?
Waypoint Bio is based in New York City, United States, founded in 2021.
How much has Waypoint Bio raised?
Waypoint Bio has raised $20M in tracked funding and is currently at the series-a stage.
Who has invested in Waypoint Bio?
Investors in Waypoint Bio include Hummingbird Ventures, Recode Ventures, Fifty Years, Builders VC, Dimension Capital, FPV Fund, Kinnevik and True Ventures.